Nobutaka Takahashi

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 114 citations

Medicine, Oncology, Pharmacotherapy +7

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata et al. · Institutional Repositories DataBase (IRDB) · 2021 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial

Masakazu Abé, Yasuyuki Hirashima, Yuka Kasamatsu et al. · Supportive Care in Cancer · 2015 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +16

Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis

Iwao Arai, Norikazu Takano, Yuki Hashimoto et al. · European Journal of Pharmacology · 2004 · 59 citations

Medicine, Dermatology, Immunology +17

Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy

Munetaka Takekuma, Yuka Kasamatsu, Nobuhiro Kado et al. · International Journal of Clinical Oncology · 2016 · 40 citations

Medicine, Oncology, Surgery +17